Javier G Blanco

3PUBLICATIONS
14CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 01, 2025
FDA Approval Summary: Ivosidenib for Treatment of Adult Patients with Relapsed/Refractory Myelodysplastic Syndrome with an IDH1 Mutation.

Ashley C Woods, E Dianne Pulte, Xin Wang

|May 12, 2021
CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin.

Jennifer K Lang, Badri Karthikeyan, Adolfo Quiñones-Lombraña

|Jun 01, 2018
CBR1 rs9024 genotype status impacts the bioactivation of loxoprofen in human liver.

Adolfo Quiñones-Lombraña, Nasi Li, Virginia Del Solar

Pageof 1